Evidence synthesis Promising, with limits 10 trials with 1,030 people who had IBS
Oral peppermint-oil products for IBS: a signal with very low certainty
Across ten trials, oral peppermint-oil products outperformed placebo for overall IBS symptoms and abdominal pain. Adverse events were also more common. The reviewers rated the evidence very low quality, and the abstract does not establish that every product used the same coating or release system.
- What was studied
- Oral peppermint-oil formulations used in IBS trials; not peppermint tea, food flavoring, inhaled oil, or topical oil
- Setting
- Studied alone
- Why it ranks here
- The pooled symptom results favored peppermint oil, but the uncertainty was wide, adverse events increased, and the reviewers judged the evidence very low quality.
Limits and cautions
- The review rated the overall evidence very low quality.
- The confidence interval around the number needed to treat for global symptoms was very wide.
- Any adverse event was more frequent with peppermint oil than with placebo.
- The abstract does not list all adverse-event types or severities.
- Coating and release system can affect where the oil is released and how well it is tolerated.
This card does not recommend swallowing peppermint essential oil or improvising a product. Persistent pain, bleeding, weight loss, fever, or a major change in bowel habits needs medical evaluation.